Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy
Michael Hiltensperger(TUM Klinikum), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jürgen Ruland(Technical University of Munich)
Cited by 0
Related Papers
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
|Science Immunology|2022|280
PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis
|Nature|2017|245
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy
|Cell|2024|227
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
|Blood|2020|191
Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
|Nature Biomedical Engineering|2019|179